Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

119
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
119
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

55
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

38
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
38

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular Disease Update: Peripheral Artery Disease.

FP essentials·2025
Same author

Cardiovascular Disease Update: Medical Management of Chronic Coronary Disease.

FP essentials·2025
Same author

Cardiovascular Disease Update: Heart Failure Update.

FP essentials·2025
Same author

Mindfulness-Enhanced Parenting Programs Improve the Psychosocial Outcomes of Children up to 18 Years and Their Parents.

American family physician·2024
Same author

Combined Oral Contraceptives for Primary Dysmenorrhea.

American family physician·2024
Same author

Aspirin Use and the Risk of Mortality in Patients With Hypertension.

American family physician·2023

Related Experiment Video

Updated: Sep 10, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K

Cardiovascular Disease Update: Coronary Artery Disease Risk Assessment and Noninvasive Testing.

Joseph M Sapoval1, Kevin A Bobeck2, Anthony M Recidoro3

  • 1Jacksonville Family Medicine Residency Program at Naval Hospital Jacksonville, Jacksonville, FL.

FP Essentials
|August 19, 2025
PubMed
Summary

Cardiovascular disease risk assessment is advancing with personalized tools like the PREVENT calculator. Lipoprotein(a) and coronary artery calcium scoring aid in risk stratification for specific patient groups.

More Related Videos

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

525
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.0K

Related Experiment Videos

Last Updated: Sep 10, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

525
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.0K

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Biomarkers

Background:

  • Cardiovascular disease risk assessment is evolving, moving towards personalized patient recommendations.
  • Pooled cohort equations form the basis of risk assessment for individuals aged 40-75.
  • The PREVENT calculator is a newer tool succeeding the 2013 ACC/AHA pooled cohort equation, with similar predictive performance.

Purpose of the Study:

  • To review current cardiovascular disease risk assessment strategies.
  • To highlight emerging tools and biomarkers for risk stratification.
  • To discuss the role of specific tests in primary prevention.

Main Methods:

  • Review of current guidelines and emerging research in cardiovascular risk assessment.
  • Evaluation of the utility of calculators, biomarkers, and imaging techniques.
  • Analysis of treatment goals for primary prevention.

Main Results:

  • Pooled cohort equations and newer calculators like PREVENT provide foundational risk assessment.
  • Lipoprotein(a) is valuable for patients with family history or dyslipidemia.
  • Coronary artery calcium scoring can reclassify risk in intermediate-risk patients, though outcome data is limited.
  • Routine electrocardiography is not recommended for screening.

Conclusions:

  • Cardiovascular risk assessment is becoming more personalized.
  • Specific biomarkers and imaging can refine risk stratification beyond traditional calculators.
  • Current primary prevention focuses on significant LDL cholesterol reduction for statin candidates.